Showing results (151-160 of 182) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2025
Micellar formulation provides potent and tolerable TLR7 agonist treatment for anti-cancer immunotherapyEsben Christensen, Camilla Stavnsbjerg, Rasmus Münter, et al.
Diabetes Care|November 15, 2012
Association between urinary markers of nucleic acid oxidation and mortality in type 2 diabetes: a population-based cohort studyKasper Broedbaek, Volkert Siersma, Trine Henriksen, et al.
Plos One|January 10, 2014
T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replicationRandi K Berg, Stine H Rahbek, Emil Kofod-Olsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2013
IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replicationMartin R Jakobsen, Rasmus O Bak, Annika Andersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2011
Combinations of polymorphisms in genes involved in the 5-Fluorouracil metabolism pathway are associated with gastrointestinal toxicity in chemotherapy-treated colorectal cancer patientsShoaib Afzal, Milena Gusella, Ben Vainer, et al.
Nature Plants|August 8, 2018
Individual components of paired typical NLR immune receptors are regulated by distinct E3 ligasesOliver Xiaoou Dong, Kevin Ao, Fang Xu, et al.
Redox Biology|December 16, 2014
Urinary markers of nucleic acid oxidation and cancer in type 2 diabetesKasper Broedbaek, Volkert Siersma, Trine Henriksen, et al.
JAMA|April 7, 2011
Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysisJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Diabetes Care|October 14, 2011
Urinary markers of nucleic acid oxidation and long-term mortality of newly diagnosed type 2 diabetic patientsKasper Broedbaek, Volkert Siersma, Trine Henriksen, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 15, 2013
Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trialHayk Davtyan, Anahit Ghochikyan, Irina Petrushina, et al.
Pageof 19